Neural Respiratory Drive of Patients With Chronic Obstructive Pulmonary Disease

NCT05786950 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: compound ipratropium bromide solution (3mg salbutamol and 500μg ipratropium, Boehringer Ingelheim Limited, Germany)

Sponsor

The First Affiliated Hospital of Guangzhou Medical University